TSW
ELAN icon

Thompson Siegel & Walmsley’s Elanco Animal Health ELAN Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-108
Closed -$2K – 655
2020
Q2 		$2K Hold
108
– – ﹤0.01% 634
2020
Q1 		$2K Hold
108
– – ﹤0.01% 622
2019
Q4 		$3K Buy
+108
New +$2.94K ﹤0.01% 690

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Thompson Siegel & Walmsley's ELAN Position: Q3 2020 in Review

Thompson Siegel & Walmsley sold out of Elanco Animal Health (ELAN) in Q3 2020, closing a stake of 108 shares — an estimated $2K sold.

Thompson Siegel & Walmsley first reported a position in ELAN in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q4 2019. 360 funds tracked by Wall St. Rank hold ELAN as of Q3 2020.

  • Thompson Siegel & Walmsley reported no remaining Elanco Animal Health position as of Q3 2020 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 108 Elanco Animal Health shares in Q3 2020, an estimated $2K.
  • Thompson Siegel & Walmsley first reported a position in Elanco Animal Health in Q4 2019 and held it in 3 quarters.
  • Thompson Siegel & Walmsley's Elanco Animal Health position peaked at $3K in Q4 2019.
  • 360 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2020, filed 12 Nov 2020.